tm logo
ANVIRZEL
Live/Registered
REGISTERED AND RENEWED

on 13 Jan 2024

Last Applicant/ Owned by

COLONIA CASTAÑO SUR, AVENIDA RAMÓN

TEGUCIGALPA

HN

Serial Number

85303529 filed on 25th Apr 2011

Registration Number

4366648 registered on 16th Jul 2013

in the Principal Register

Correspondent Address

William B. Nash

William B. Nash

2323 Victory Avenue, Suite 700

Dallas,TX 75219

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

ANVIRZEL

pharmaceutical preparations used in the treatment of cancer, HIV/AIDS, hepatitis C, herpes and other viral diseases, strokes, Alzheimer's and other neuro-degenerative diseases

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations used in the treatment of cancer, HIV/AIDS, hepatitis C, herpes and other viral diseases, strokes, Alzheimer's and other neuro-degenerative diseases


First Use Date in General

31st Dec 2006

First Use Date in Commerce

31st Dec 2006

Specimens


ANVIRZEL specimenANVIRZEL specimenANVIRZEL specimenANVIRZEL specimenANVIRZEL specimenANVIRZEL specimen

Mark Details


Serial Number

No 85303529

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 70824.2US01

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Jan 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Jan 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13th Jan 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
13th Jan 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
17th Jul 2023TEAS SECTION 8 & 9 RECEIVED
14th Jun 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
16th Jul 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
26th Jul 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
26th Jul 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
25th Jul 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL